Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately.
●(See "Society guideline links: Chronic kidney disease in children".)
●(See "Society guideline links: Chronic kidney disease-mineral and bone disorder".)
●(See "Society guideline links: Anemia in chronic kidney disease".)
●(See "Society guideline links: Dialysis".)
International
●American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO): Consensus report for diabetes management in chronic kidney disease (2022)
●KDIGO: Clinical practice guideline for diabetes management in chronic kidney disease (2022)
●KDIGO: Clinical practice guideline on the management of blood pressure in chronic kidney disease (2021)
●KDIGO: Clinical practice guideline for nutrition in CKD, update (2020)
●KDIGO: Clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease (2018)
●International Society of Renal Nutrition and Metabolism (ISRNM): Consensus statement on the etiology of the protein-energy wasting syndrome in chronic kidney disease (2013)
●ISRNM: Consensus statement on the prevention and treatment of protein energy wasting in chronic kidney disease patients (2013)
●KDIGO: Clinical practice guideline for lipid management in chronic kidney disease (2013)
●KDIGO: Clinical practice guideline for the evaluation and management of chronic kidney disease, 2012 (published 2013)
●KDIGO: Clinical practice guideline for anemia in chronic kidney disease (2012)
●International Society of Nephrology (ISN) and International Pediatric Nephrology Association (IPNA): Consensus statement on transition from pediatric to adult renal services (2011)
Canada
●Choosing Wisely Canada: Don't initiate dialysis in outpatients with Stage 5 CKD in the absence of clinical indications (2019)
●Choosing Wisely Canada: Don't initiate erythropoiesis-stimulating agents (ESAs) in chronic kidney disease (CKD) patients with hemoglobin levels greater than or equal to 100 g/L without symptoms of anemia (2019)
●Choosing Wisely Canada: Don't prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) in individuals with hypertension or heart failure or CKD of all causes, including diabetes (2019)
●Diabetes Canada: Clinical practice guidelines on chronic kidney disease in diabetes (2018)
United States
●American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO): Consensus report for diabetes management in chronic kidney disease (2022)
●National Kidney Foundation (NKF) and the American Society of Nephrology (ASN): A unifying approach for GFR estimation – Recommendations on reassessing the inclusion of race in diagnosing kidney disease (2021)
●American College of Radiology (ACR): ACR Appropriateness Criteria on renal failure (2020)
●Choosing Wisely: Don't request just a serum creatinine to test adult patients with diabetes and/or hypertension for CKD; use the Kidney Profile (serum Creatinine with eGFR and urinary albumin-creatinine ratio) (2018)
●Centers for Disease Control and Prevention (CDC): Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease (2012, reviewed 2015)
●Department of Veterans Affairs (VA)/Department of Defense (DoD): Clinical practice guideline for the management of chronic kidney disease in primary care, 3rd edition (2014)
●Infectious Diseases Society of America (IDSA): Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV, update (2014)
●Choosing Wisely: Avoid nonsteroidal anti-inflammatory drugs (NSAIDs) in individuals with hypertension or heart failure or CKD of all causes, including diabetes (2012)
●Choosing Wisely: Don't administer erythropoiesis-stimulating agents (ESAs) to chronic kidney disease (CKD) patients with hemoglobin levels greater than or equal to 10 g/dL without symptoms of anemia. (2012)
●Choosing Wisely: Don't place peripherally inserted central catheters (PICC) in stage III-V CKD patients without consulting nephrology (2012)
●NKF: Clinical practice guideline for diabetes and CKD, update (2012)
●American Society of Parenteral and Enteral Nutrition (ASPEN): Clinical guidelines – Nutrition support in adult acute and chronic renal failure (2010)
●American Society of Diagnostic and Interventional Nephrology (ASDIN) and Association for Vascular Access (AVA): Guidelines for venous access in patients with chronic kidney disease (2008)
Europe
●European Renal Best Practice (ERBP): Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2) (2016)
●European Renal Association (ERA)-European Dialysis and Transplant Association (EDTA): Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? – A position statement (2015)
●ERBP: Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) (2015)
●ERBP: Position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease – An endorsement with some caveats for real-life application (2013)
●ERBP: Anaemia management in patients with chronic kidney disease – A position statement (2009)
●European Society for Clinical Nutrition and Metabolism (ESPEN): Guidelines on parenteral nutrition – Adult renal failure (2009)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Guideline on chronic kidney disease – Assessment and management (2021)
●The Renal Association (RA): Clinical practice guideline – Anaemia of chronic kidney disease (2017, updated 2020)
●RA: Clinical practice guideline – Pregnancy and renal disease (2019)
●RA: Clinical practice guideline – Undernutrition in chronic kidney disease (2019)
●NICE: Diagnostics guidance on multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis (2017)
●NICE: Quality standard on chronic kidney disease in adults (2011, updated 2017)
●NICE: Clinical guideline on chronic kidney disease (stage 4 or 5) – Management of hyperphosphataemia (2013)
Australia-New Zealand
●Caring for Australasians with Renal Impairment (CARI): Chronic kidney disease guidelines
●Kidney Health Australia (KHA): Chronic kidney disease (CKD) management in general practice – Guidelines and clinical tips to help identify, manage and refer patients with CKD in your practice, 3rd edition (2015)
●New Zealand Ministry of Health: Managing chronic kidney disease in primary care – National consensus statement (2015)
●Exercise and Sports Science Australia (ESSA): Position statement on exercise and chronic kidney disease (2013)
●Diabetes Australia (DA): National evidence based guideline for diagnosis, prevention and management of chronic kidney disease in type 2 diabetes (2009)
Japan
●[In English] Japanese Society of Nephrology (JSN): Essential points from evidence-based clinical practice guideline for chronic kidney disease, 2018 (published 2019)
●[In Japanese] JSN: Evidence-based clinical practice guideline for CKD (2018)
●[In English] Japanese Society for Dialysis Therapy (JSDT): Guidelines for renal anemia in chronic kidney disease, 2015 (published 2017)
●[In Japanese] JSN: Clinical practice guidelines for the management of pregnancy in kidney disease patients (2017)
●[In Japanese] JSN: Smooth transition to prevention of kidney damage progression and renal replacement therapy – CKD stage G3b-5 clinical practice guideline (2017)
●[In Japanese] JSDT: Guidelines for the treatment of renal anemia in patients with chronic kidney disease, 2015 (published 2016)
●[In Japanese] JSN: Recommendations for reducing the number of new dialysis patients from lifestyle-related diseases – Prevention and early detection of CKD (chronic kidney disease) (2016)
●[In English] Asian Forum for Chronic Kidney Disease Initiative (AFCKDI): Asian chronic kidney disease best practice recommendations – Positional statement for early detection of chronic kidney disease (2011)
